Costs And Benefits Of Routine Varicella Vaccination In German Children

Philippe Beutels, R. Clara, G. Tormans, +2

The Journal of Infectious Diseases

Cost-effectiveness RatioVaccine HesitancyPreventive MedicinePediatric EpidemiologyVaccine Surveillance +14

Cost‐effectiveness analysis of vaccination against hepatitis A in travellers

Eddy van Doorslaer, G. Tormans, Pierre Van Damme

Journal of Medical Virology

VaccinationVaccine SafetyActive ImmunisationPreventive MedicineViral Hepatitis +13

Cost-effectiveness analysis of hepatitis A prevention in travellers

G. Tormans, Pierre Van Damme, Eddy van Doorslaer

Vaccine

Cost-effectiveness AnalysisPreventive MedicineHealth EconomicsViral HepatitisDisease Prevention +5

Hepatitis B prevention in Europe: a preliminary economic evaluation

Pierre Van Damme, G. Tormans, Philippe Beutels, +1

Vaccine

Preventive MedicineHealth EconomicsViral HepatitisDisease PreventionHepatitis B +6

Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany

G. Tormans, Eddy van Doorslaer, Pierre Van Damme, +2

European Journal of Pediatrics

VaccinationVaccine SafetyPreventive MedicineVaccine DevelopmentHealth Economics +8

Economic Evaluation of Antifungal Agents in the Treatment of Toenail Onychomycosis in Germany

Eddy van Doorslaer, G. Tormans, Aditya K. Gupta, +5

Dermatology

An economic evaluation of universal pertussis vaccination in Italy

Philippe Beutels, Paolo Bonanni, G. Tormans, +2

Vaccine

VaccinationPreventive MedicineHealth EconomicsVaccine EfficacyInfection Control +4

Cost-effectiveness analysis of prenatal screening and vaccination against hepatitis B virus—The case of Belgium

G. Tormans, Pierre Van Damme, Guy Carrin, +2

Social Science & Medicine

VaccinationPreventive MedicineCost-effectiveness AnalysisHealth EconomicsHealth Policy +10

An economic evaluation of hepatitis A vaccination in Dutch military personnel.

Adriaan Hopperus Buma, Philippe Beutels, Pierre Van Damme, +3

PubMed

VaccinationVaccine SafetyInactivated HepatitisVaccine DevelopmentHealth Economics +12

Recommendations for Prevention of Hepatitis A Based on a Cost-Effectiveness Analysis

G. Tormans, Pierre Van Damme, Eddy van Doorslaer

Journal of Travel Medicine

Cost-effectiveness AnalysisHepatitis APreventive MedicineViral HepatitisInfection Control +17